BD Discardit 2ml Syringe with 21g Needle - each
847197
This 2ml syringe with an attached 21-gauge (21g) needle is suitable for administering specific medications to cats and dogs that require subcutaneous injections. Each syringe is individually packaged, sterile, and designed for single use only. This product is commonly used in veterinary practices and at home under veterinary guidance.
The syringe has a 2ml capacity and is fitted with a 21g needle. This needle size is considered suitable for administering certain subcutaneous or intramuscular injections in cats and dogs, depending on the medication and the animal’s size and condition. The 21g needle offers a balance between needle strength and minimal discomfort during injection, making it appropriate for routine use with specific veterinary biologics.
This type of syringe is appropriate for administering Solensia, Librela, and Cytopoint, which are injectable monoclonal antibody therapies used to manage chronic pain and allergic dermatitis in pets. These medications are typically prescribed for monthly administration and are given via subcutaneous injection. The 21g needle provides a suitable gauge for delivering the full dose efficiently while maintaining comfort for the animal.
Solensia is prescribed for the management of osteoarthritis pain in cats. It is given once a month via subcutaneous injection. The 2ml syringe allows for accurate dosing, and the 21g needle is appropriate for the viscosity of the Solensia solution and for delivering it under the skin in a cat with minimal stress and tissue trauma.
Librela is used in dogs to treat pain associated with osteoarthritis. Like Solensia, it is administered subcutaneously once a month. The 21g needle is appropriate for most dog breeds and sizes, as it enables smooth delivery of the medication while being strong enough to penetrate the skin effectively without bending or breaking.
Cytopoint is another monoclonal antibody therapy, used to manage allergic dermatitis in dogs. It is also given as a monthly subcutaneous injection. The 2ml capacity of the syringe provides ample volume to accommodate the required dose, and the 21g needle is compatible with the formulation’s consistency and administration method.
This syringe and needle combination should not be used for insulin administration in cats or dogs. Veterinary insulin products such as Caninsulin and Prozinc require specific insulin syringes that are calibrated differently from standard 2ml syringes. Insulin syringes are typically marked in units, not millilitres, and have finer, shorter needles such as 29g or 30g, which are designed to deliver precise insulin doses in small volumes. Using a standard 2ml syringe for insulin injections can lead to inaccurate dosing and can be dangerous to the animal.
More Information
Description
Caninsulin and Prozinc are insulins specifically formulated for veterinary use and have unique concentration requirements—Caninsulin, for example, is 40 IU/ml, which is incompatible with syringes calibrated for human insulin (100 IU/ml). Insulin syringes are essential for these medications to ensure proper dosing and to reduce the risk of hypoglycaemia or underdosing. The 21g needle on this syringe is also too large and inappropriate for the fine control needed with insulin injections.
The 2ml syringe with 21g needle is equipped with clear volume markings along the barrel, which helps ensure accurate dose measurement. The plunger moves smoothly within the barrel, allowing for controlled and consistent administration of medication. The syringe and needle are securely attached, reducing the risk of detachment during use.
The syringe is made from medical-grade materials that comply with health and safety standards for veterinary injections. It is intended for single-use to prevent contamination and cross-infection. After use, syringes should be disposed of safely in an appropriate sharps container, in accordance with local veterinary or environmental guidelines.
These syringes are commonly used in both professional veterinary settings and for home administration by pet owners, following instruction from a veterinary surgeon. Handling instructions and injection techniques should always be followed as advised by the prescribing professional. Administering injectable medications without proper training or guidance is not recommended.
You may also like
15mg Librela Solution for Dogs - 2 Vials
15mg Librela is an innovative drug for the alleviation of pain associated with osteoarthritis in dogs.
Librela 15mg is a revolutionary solution that provides effective relief from osteoarthritis pain in dogs, with a safety profile supported by studies. It differs from traditional NSAIDs by specifically targeting Nerve Growth Factor (NGF), an essential cause of osteoarthritis pain.
Librela is a refrigerated medication - We will send it via Royal Mail Special Delivery using insulated packaging and ice packs. A signature is required on delivery and it must be put straight into a fridge. We cannot guarantee same day dispatch for orders placed after 12pm. VETERINARY PRESCRIPTION REQUIRED.
Librela is a monoclonal antibody, replicating the function of naturally occurring antibodies. It is removed via standard protein degradation pathways, resulting in a low-impact treatment on the liver or kidneys and minimal gastrointestinal effects. Clinical studies indicate increased mobility and reduced pain in dogs after the initial Librela injection.
20mg Librela Solution for Dogs - 2 Vials
Librela 20mg is a new injecton used for arthritis pain relief in dogs. Librela is scientifically proven to ease pain effectively for an entire month. With minimal liver, kidney, and GI involvement, Librela's monoclonal antibodies offer a safer, more natural approach to treating osteoarthritis in dogs.
Librela provides an innovative alternative to NSAIDs by targeting the Nerve Growth Factor (NGF), known for inducing pain and inflammation in osteoarthritis. Dogs show a marked increase in mobility and reduction in pain after the first dose, making it an ideal choice for pain management. Librela is administered as a subcutaneous injection, usually once a month, by a veterinary surgeon or at home if your Vet has given you some training.
Librela is a refrigerated medication - We will send it via Royal Mail Special Delivery using insulated packaging and ice packs. A signature is required on delivery and it must be put straight into a fridge. We cannot guarantee same day dispatch for orders placed after 12pm. VETERINARY PRESCRIPTION REQUIRED.
Librela 20mg is a caninised monoclonal antibody. Each vial of 1ml Librela contains 20mg bedinvetmab and enhances the natural process of clearing away immune complexes, thus avoiding pain signals from reaching the brain and causing neuropathic pain.
Osteoarthritis, often referred to as arthritis, is a long-term joint condition that causes pain, stiffness and reduced mobility. Dogs may find it harder to rise after rest, climb stairs, jump into the car, or keep up on walks. Managing pain can help maintain activity and muscle, which supports joint function.
Osteoarthritis commonly affects weight-bearing joints such as hips, elbows and knees, but it can also involve the spine. When a dog moves less due to pain, muscle support reduces and joints can become stiffer, which may worsen the cycle of discomfort. For this reason, long-term management often focuses on keeping movement comfortable and consistent, rather than waiting until a dog is severely lame.
How 20mg Librela works
Librela contains bedinvetmab, a canine monoclonal antibody. A monoclonal antibody is a targeted protein therapy designed to bind to a specific substance in the body. Bedinvetmab targets nerve growth factor (NGF), which is involved in pain signalling and in the "turning up" of pain sensitivity.
In osteoarthritis, NGF activity around affected joints can contribute to ongoing discomfort. When bedinvetmab binds to NGF, it helps reduce NGF‑mediated signalling. This can lower pain signalling from the joint and improve comfort. Librela does not repair cartilage or reverse structural joint changes. It is intended to manage pain so that supportive measures, such as controlled exercise and weight management, are easier to maintain.
30mg Librela Solution for Dogs - 2 Vials
30mg Librela for Dogs is a vet-prescribed monthly injection that targets Nerve Growth Factor (NGF) to relieve osteoarthritis pain in dogs, helping improve comfort, mobility and daily activity at home.
Librela is a refrigerated medication - We will send it via Royal Mail Special Delivery using insulated packaging and ice packs. A signature is required on delivery and it must be put straight into a fridge. We cannot guarantee same day dispatch for orders placed after 12pm. VETERINARY PRESCRIPTION REQUIRED.
Osteoarthritis (Arthritis) is a long-term joint condition. In a healthy joint, smooth cartilage covers the ends of the bones and helps them glide with minimal friction. The joint also contains lubricating fluid and supportive tissues that keep movement stable. With osteoarthritis, cartilage gradually becomes damaged and less effective at cushioning. The joint lining can become inflamed, the joint can thicken, and movement can become painful and stiff. Dogs may avoid using the joint fully, which can lead to reduced muscle strength and poorer joint stability.
Osteoarthritis is common in older dogs, but it can develop at any age. Previous joint injury, repeated strain, and inherited joint conformation issues (such as hip or elbow dysplasia) can all contribute. Excess body weight is also important because it increases the load on painful joints and can worsen stiffness.
Librela 30mg contains bedinvetmab, which is a monoclonal antibody. Monoclonal antibodies are designed to target a specific molecule in the body. Bedinvetmab targets nerve growth factor (NGF), a signalling molecule involved in pain pathways. In osteoarthritis, NGF can contribute to ongoing pain by increasing the sensitivity of nerves in and around affected joints.
Because osteoarthritis is ongoing, Librela is usually repeated every month to help maintain consistent pain control. Your vet may suggest tracking changes in your dog’s daily activity and comfort, because gradual improvements can be easier to spot when you look back over a few weeks. If your dog’s mobility suddenly worsens, if they show new pain, or if you notice any change that concerns you, you should contact your veterinary practice for advice.
Solensia for Cats - 7mg/ml - Pack of 2
Solensia for Cats is a prescription veterinary medicine used to help control pain associated with osteoarthritis (arthritis) in cats. It is given as a monthly injection by a veterinary professional or at home after training. Solensia is intended for cats that are showing pain-related changes such as stiffness, reduced willingness to jump, reluctance to climb, or reduced interest in play. Many cats with arthritis do not limp, so treatment is often based on the pattern of changes you notice at home alongside your vet’s examination findings.
Solensia is a refrigerated medication - We will send it via Royal Mail Special Delivery using insulated packaging and ice packs. A signature is required on delivery and it must be put straight into a fridge. We cannot guarantee same day dispatch for orders placed after 12pm. VETERINARY PRESCRIPTION REQUIRED.
Osteoarthritis is a long-term condition in which joints become less comfortable and less flexible. Cartilage can wear, the joint capsule can thicken, and tissues around the joint can become sensitive. Cats are skilled at hiding discomfort and they often adapt quietly by moving less. They may choose lower resting places, stop using high shelves, hesitate before jumping onto sofas and windowsills, or take longer routes that avoid climbing. Because these changes can happen gradually, arthritis can be present for some time before it becomes obvious.
Solensia contains frunevetmab, which is a monoclonal antibody. A monoclonal antibody is a targeted protein designed to attach to one specific substance in the body. In this case, Solensia binds to nerve growth factor (NGF). NGF plays an important role in activating and maintaining pain signals. In osteoarthritis, NGF released in and around affected joints can contribute to ongoing pain signalling from the joint to the nervous system. By binding to NGF, Solensia reduces NGF’s ability to activate its receptors and drive pain pathways. This can help reduce pain associated with osteoarthritis and support more comfortable movement.
Solensia works differently from anti-inflammatory medicines such as non-steroidal anti-inflammatory drugs (NSAIDs). NSAIDs mainly act by reducing the production of inflammatory mediators. Solensia targets NGF within the pain signalling process. Because it is a monthly injection rather than a daily oral medicine, it can be helpful for cats that are difficult to medicate at home. Your vet will decide whether Solensia is suitable for your cat, and whether any other treatments are needed alongside it.